Nova Ltd. (NVMI) | The Buildout — AI Infrastructure
The Verdict
Nova Ltd. makes the measurement and process-control tools that semiconductor fabs use to check wafers as they are made. It does not build chips, and it does not build the process tools that print or deposit them; it sells the metrology layer that sits alongside — film thickness, critical dimension, materials and X-ray measurement. The mechanism management cites is that as chipmakers pack more complexity into logic, memory and advanced packaging, the number of critical measurement steps per wafer rises, so demand grows with process intensity and not just with wafer volume. The company sells to the world's largest integrated-circuit manufacturers, across logic, memory and advanced packaging.
| Market Cap | — |
| Revenue (TTM) | $938M |
| Revenue Growth | +16.1% |
| EBITDA Margin (TTM) | 31.5% |
| Net Cash | $218M |
| Earnings Beats | 7 of 7 |
| P/E (TTM) | — |
| EV/EBITDA (TTM) | — |
What We Like
- Revenue rose from $517.9M in FY2023 to $880.6M in FY2025 — 70% growth in two years (20-F).
- Q2 FY2026 revenue was a record $255.0M, up 16% year over year and at the top of the $245–255M guided range.
- Management reaffirmed a $1B revenue target for 2027 as on track, and the $500M cumulative gate-all-around revenue target for 2024–2026 as on track.
- Gartner data cited by management shows a ~400 basis point share gain in film and critical-dimension metrology in 2025 — a second consecutive year — making Nova the market's second-largest vendor.
- The balance sheet held $124.8M of cash plus $896.2M of short-term investments against $803.5M of total debt at 2026-06-30 — a net cash position of $217.5M.
What We’re Watching
- Gross margin held at the top of the 57%–60% model in Q1 FY2026 (57.7% GAAP) but slipped to 56.5% in Q2. Management promises full-year 2026 margin within the first-half rate while flagging unquantified supplier cost pressure tied to higher chip prices.
- Emerging XPS and material-metrology competition — including a local vendor in China — was disclosed for the first time on the latest call and is unquantified. Watch for any effect on share or pricing in a core product line.
- Memory rose from roughly 25% to 34% of revenue, and management expects it more dominant in 2026. The margin consequence of a DRAM-heavy mix versus logic is not disclosed, so it has to be inferred from the blend.
- Q2 operating expenses were guided up to roughly $72M GAAP from $64.9M in Q1. Watch whether that is a one-quarter investment or a new run-rate that pressures the 28%–33% operating-margin model.
The demand side of the thesis looks like it is strengthening. Management raised its 2026 wafer-fab equipment view to mid-teens growth and reaffirmed the $1B 2027 revenue target, memory climbed to 34% of revenue, and Q2 FY2026 revenue landed at the top of the guided range. Margins are being held at the top of the 57%–60% gross-margin model rather than expanded, and the Q2 gross margin slipped to 56.5% from 57.7%. Two unquantified caution flags — supplier cost pressure and newly disclosed XPS competition — arrived on the most recent earnings call. The biggest open question is whether Nova's mid-teens WFE framing is conservative or definitional, since it sits below process-tool peers talking growth "well into the 20s."
Earnings Beat
Nova reported record Q2 FY2026 revenue of $255.0M on 2026-08-06 — up 8% quarter over quarter and 16% year over year, and at the top of the $245–255M range management guided on its prior call. Gross margin was 56.5%, down from 57.7% in Q1 FY2026. Q2 came from a press release only; no earnings call or updated guidance for the quarter is in the source material.
| Metric | Q2 FY2026 | Q1 FY2026 | Q2 FY2025 | YoY |
|---|---|---|---|---|
| Revenue | $255M | $235M | $220M | +15.9% |
| Gross margin | 56.5% | 57.7% | 57.8% | -130bps |
| EBITDA | $82M | $77M | $71M | +15.6% |
| EPS | $2.17 | $2.01 | $2.13 | +2.2% |
we expect WFE to reach mid-teens growth, and this is higher than what we were looking at back in February. We are expecting to outperform this number.— Gaby Waisman, CEO, 2026-05-14
Management tone: The most recent earnings call in the source is Q1 FY2026, dated 2026-05-14; there is no Q2 FY2026 call in the material. On that call, management's tone stepped up versus the prior call. They volunteered two upgrades — a raised 2026 WFE view (low double digits to mid-teens) and a higher memory mix (roughly 25% to 34% of revenue) — and added forward-dated disclosures that had not been quantified before, including the Asia facility's operational date and 2027 order activity. They were direct on gross-margin sustainability and on 2027 visibility, reframed the process-control relative-growth question as 'too early to call,' and downplayed the Q2 gross-margin step-down as normal guidance variance. They also volunteered two negatives: supplier cost pressure and emerging XPS competition.
Management Guidance
Management gave no full-year revenue or EPS guidance. On the Q1 FY2026 call (2026-05-14), it guided Q2 FY2026 revenue to $245M–$255M, gross margin to ~57% GAAP / ~59% non-GAAP, operating expenses to ~$72M GAAP / ~$66M non-GAAP, an effective tax rate of ~15%, and EPS of $2.10–$2.24 GAAP / $2.34–$2.48 non-GAAP; Q2 revenue landed at the top of that range at $255.0M. For the full year, management said 2026 gross margin will be 'within the same rate' as first-half guidance and 'sustainable during the year,' reaffirmed the 57%–60% gross-margin and 28%–33% operating-margin target models, and said H2 2026 will run higher than H1.
Trajectory
Revenue grew from $517.9M in FY2023 to $880.6M in FY2025 (up 70%) and reached a record $255.0M in Q2 FY2026. The code-computed labels call the revenue trend DECELERATING: year-over-year growth slid from about +50% in Q1 FY2025 to +10% in Q1 FY2026, before ticking back to +16% in Q2. Sequentially the business is still growing — Q1 +5.7% and Q2 +8.4% quarter over quarter. Margins are stable at the gross line, between 56.5% and 57.7% across the last four quarters, while operating and EBITDA margins have expanded. Trailing free cash flow of $189.7M converted 70% of trailing net income of $270.4M. Management attributes the growth to AI-driven capacity expansion and rising metrology intensity in advanced DRAM, advanced packaging and gate-all-around logic.
The Model
The model projects FY+1 revenue of $1,045M with EBITDA of $341M (32.6% margin), rising to FY+2 revenue of $1,250M and EBITDA of $415M (33.2% margin). The near-term anchor is the Q2 FY2026 revenue run-rate of $255.0M, management's raised mid-teens 2026 WFE view with an expectation to outperform it, and 2027 order activity already being booked. The FY+2 step-up rests on the demand vectors management points to — advanced DRAM and HBM, advanced packaging and hybrid bonding, and gate-all-around logic — plus the new Asia production facility, slated to become operational toward the end of 2026.
| Metric | FY2025 | Next FY (E) | Following FY (E) |
|---|---|---|---|
| Revenue | $881M | $1.0B | $1.2B |
| YoY Growth | — | +18.7% | +19.6% |
| EBITDA | $276M | $341M | $415M |
| EBITDA Margin | 31.3% | 32.6% | 33.2% |
Projections are the median of 5 independent model runs. The model’s revenue sits 3.5% below analyst consensus.
Management gave no full-year revenue or EPS guidance. On the Q1 FY2026 call (2026-05-14), it guided Q2 FY2026 revenue to $245M–$255M, gross margin to ~57% GAAP / ~59% non-GAAP, operating expenses to ~$72M GAAP / ~$66M non-GAAP, an effective tax rate of ~15%, and EPS of $2.10–$2.24 GAAP / $2.34–$2.48 non-GAAP; Q2 revenue landed at the top of that range at $255.0M. For the full year, management said 2026 gross margin will be 'within the same rate' as first-half guidance and 'sustainable during the year,' reaffirmed the 57%–60% gross-margin and 28%–33% operating-margin target models, and said H2 2026 will run higher than H1.
What Could Go Right — and Wrong
- If H2 2026 revenue runs higher than H1, as management expects, the company's $1B 2027 revenue target could be approached or reached early.
- Hybrid bonding converts from qualitative traction into named design wins or disclosed revenue, lifting metrology content per advanced package.
- Memory holds at or above 34% of revenue and management discloses a favorable margin read on advanced DRAM, turning the mix shift into visible earnings power.
- The Asia production facility lands on schedule, with the capacity and cost-structure benefits supporting gross margin above the 57%–60% model.
- Gate-all-around spending grows in 2027 versus 2026, as management expects, extending the leading-edge logic contribution beyond the $500M cumulative target.
- Memory, at 34% of revenue and rising, is the most cyclical end market; a DRAM or HBM capex pause would hit the largest growth vector, and Nova's short lead times mean it would transmit quickly.
- Emerging XPS and material-metrology competition, including a local Chinese vendor, shows up in share or pricing in a core franchise.
- Supplier cost pressure tied to higher chip prices breaks the full-year gross-margin promise and pulls margin below the 57%–60% model.
- The Q2 opex step-up to roughly $72M GAAP proves structural rather than a one-quarter investment, pressuring the 28%–33% operating-margin model.
- China revenue, 33% of 2025, declines faster than the guided 25%–30% long-term range, or at a worse price.
Looking Ahead
Over the next 12 months the questions are whether demand converts and whether margins hold. Management expects H2 2026 to run higher than H1, has promised full-year gross margin within the first-half rate, and expects Nova to outperform its mid-teens 2026 WFE view. The new Asia production facility, slated for operation toward the end of 2026, is the capacity answer to that demand. Offsetting these are two unquantified new disclosures — supplier cost pressure and emerging XPS competition — and a memory mix that now carries more cyclicality.
- H2 2026H2 revenue above H1 — Management expects H2 2026 to run higher than H1's $490.3M
- End-2026Asia facility operational — New production facility slated to start operating toward the end of 2026
- 20272027 order deliveries — Management says it is already taking orders and planning 2027 deliveries
- 2027 vs 2026Gate-all-around investment growth — Management expects GAA investments to grow in 2027 versus 2026
- 2027$1B revenue target — Management reaffirmed the $1B 2027 revenue target as on track
Financials
Annual Summary
| Metric | FY2024 | FY2025 | TTM | YoY |
|---|---|---|---|---|
| Revenue | $672M | $881M | $938M | +30.9% |
| Gross Margin | 57.7% | 57.4% | 57.1% | 32bps |
| EBITDA | $205M | $276M | $295M | +34.5% |
| EBITDA Margin | 30.5% | 31.3% | 31.5% | +82bps |
| Net Income | $184M | $259M | $270M | +41.0% |
| Free Cash Flow | $219M | $218M | $190M | — |
| Net Cash | — | — | — | — |
Key Ratios (Trailing)
- P/E TTM—
- EV/EBITDA TTM—
- EV/Revenue TTM—
- Price/FCF TTM—
- Gross Margin (TTM)57.1%
- EBITDA Margin (TTM)31.5%
- Net Margin (TTM)28.8%
- ROIC17.2%
- FCF Conversion64.2%
- SBC / Revenue2.2%
The Company
Nova Ltd. makes metrology and process-control systems for semiconductor manufacturing — the measurement layer that checks films, critical dimensions, materials and defects as wafers move through a fab. It does not make chips, and it does not make the process tools that print or deposit them; it sits alongside the process. Its own 20-F describes it as "a leading innovator and key provider of metrology solutions for advanced process control used in semiconductor manufacturing," deployed at the world's largest integrated-circuit manufacturers. Management's thesis is that AI raises metrology intensity — more critical measurement steps per wafer as devices get more complex — rather than just wafer volume.
Nova runs four main manufacturing facilities, each tied to a product line: optical CD and Raman at the Weizmann Science Park in Rehovot and at Nes Ziona, Israel; XPS and SIMS at Fremont, California; chemical metrology at Bad Urach, Germany; and optical metrology for advanced packaging at Mannheim, Germany. The company reports as a single operating segment, with the CEO as chief operating decision maker reviewing consolidated operating margin and net income. It is building a new production facility in Asia, slated to become operational toward the end of 2026, to add capacity, optimize cost structure and improve load balancing.
Business Segments
Competitive Landscape
Nova's 20-F states that it competes mainly with Onto Innovation and KLA, which make CD, thin-films and chemical metrology and process-control systems. It also competes with process-equipment makers — ASML, Lam Research and Applied Materials — which develop, or may acquire companies that develop, in-situ sensors and metrology products. The Sentronics acquisition and the portfolio expansion into wafer-level packaging and specialty markets put Nova in direct competition with Merck and Camtek. On the Q1 FY2026 call, management named a new entrant: "emerging XPS and material metrology competition… from both a local vendor in China as well as other potential growing competition in years to come." Management describes its own position as the market's second-largest vendor.
- Onto InnovationNamed in the 20-F as a main competitor: "we compete mainly with Onto Innovation Inc., and KLA Corp., which manufacture and sell CD, thin films and chemical metrology and process control systems."
- KLANamed in the same 20-F sentence as a main competitor in CD, thin films and chemical metrology and process control.
- ASML, Lam Research, Applied MaterialsNamed in the 20-F as process-equipment makers that "develop (or may acquire companies which develop) in-situ sensors and metrology products."
- Merck and CamtekNamed in the 20-F: the Sentronics acquisition and portfolio expansion "positions us in direct competition with companies such as Merck and Camtek."
- A local Chinese XPS/material-metrology vendorNamed on the Q1 FY2026 call as emerging XPS and material-metrology competition; unnamed and unquantified.
Supply Chain
Nova buys components and subsystems from a limited supplier base, then ships metrology tools to leading-edge fabs and packaging lines. Its 20-F states it depends on a limited number of suppliers, "and in some cases a sole supplier," though no supplier is named in the filing.